title: [Leukostasis during Chronic Myelogenous Leukemia Resolved Following Leukapheresis].
abstract: Patients with hyperleucocytic leukemia (WBC count>10×10(4) mL) are at high risk of early mortality owing to pulmonary or cerebral leukostasis. Several researchers have reported the efficacy of immediate leukapheresis. Here, we report of a patient with chronic myelogenous leukemia in blast crisis and with pulmonary failure due to leukostasis who recovered after a combination therapy of leukapheresis and imatinib treatment.
authors.affiliation: Dept. of Hematology, Osaka City General Hospital.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Yoshida
authors.forename: Hideya
authors.initials: H
authors.lastname: Ueda
authors.forename: Junki
authors.initials: J
authors.lastname: Imaizumi
authors.forename: Mirei
authors.initials: M
authors.lastname: Horiuchi
authors.forename: Kiyoyuki
authors.initials: K
authors.lastname: Hagihara
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kanashima
authors.forename: Takafumi
authors.initials: T
authors.lastname: Nakao
authors.forename: Kazumi
authors.initials: K
authors.lastname: Azuma
authors.forename: Juichi
authors.initials: J
authors.lastname: Itoi
authors.forename: Takahisa
authors.initials: T
authors.lastname: Yamane
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007937:Leukapheresis; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000628:therapy*; D018921:Leukostasis / Q000209:etiology / Q000628:therapy*; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate